Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose of ciprofol for procedural sedation during spinal anesthesia across age groups
ChiCTR2400081706Phase 4Recruiting
- Sponsor
- Department of Anesthesiology, Affiliated Hospital of Jiangsu University
- Start
- Mar 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in procedural sedation and analgesia (PSA) (3 arms), sponsored by Department of Anesthesiology, Affiliated Hospital of Jiangsu University. Primary endpoints: Dosage of ciprofol during sedation, Satisfactory sedation success and 1 more. Started Mar 2024; status: recruiting.
02
Drugs
ciprofol
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on ChiCTR2400081706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081706.